Silo Pharma
SILO
7 hedge funds and large institutions have $204K invested in Silo Pharma in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
11% more capital invested
Capital invested by funds: $183K → $204K (+$20.3K)
0.03% more ownership
Funds ownership: 0.18% → 0.21% (+0.03%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
+$28.2K |
| 2 |
JP Morgan Chase
New York
|
+$423 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.43K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FAIM
1
Financial Advocates Investment Management
Olympia,
Washington
| $118K | +$28.2K | +867 | +29% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $49.8K | – | – | – |
|
3
State Street
Boston,
Massachusetts
| $25.4K | – | – | – |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $9.91K | -$1.43K | -44 | -12% |
|
|
5
JP Morgan Chase
New York
| $410 | +$423 | +13 | New |
|
|
WIM
6
Westside Investment Management
Santa Monica,
California
| $193 | – | – | – |
|
7
Wells Fargo
San Francisco,
California
| $43 | – | – | – |
|
SILO Hedge Fund Activity: Q2 2023 in Review
7 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q2 2023, worth a combined $204K — up 11% from $183K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SILO positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Financial Advocates Investment Management, adding an estimated $28.2K. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.43K.
- 7 institutional investors held Silo Pharma (SILO) as of Q2 2023, up from 6 in Q1 2023.
- Funds reported $204K of Silo Pharma stock for Q2 2023, up 11% quarter-over-quarter.
- 1 fund opened new Silo Pharma positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest Silo Pharma buyer in Q2 2023 was Financial Advocates Investment Management, an estimated $28.2K added.
- The largest Silo Pharma seller in Q2 2023 was Tower Research Capital (TRC), an estimated $1.43K sold.
Based on aggregated 13F filings for Q2 2023.